Fujisawa Pharmaceutical Company, Ltd.

Kimio Esumi

Takao Takaya

Hisashi Takasugi

Atsushi Kuno

Hiroyoshi Sakai

Kazuhiro Maeda

Yoshie Sakamoto

Tokuaki Kajiho

Haruo Horiai

Yukio Motoyama

Hiroyuki Mizuo

The present invention relates to a pharmaceutical composition for the prevention and/or the treatment of dialysis-induced hypotension and/or hypotension after dialysis which comprises, as an active ingredient, a pyrazolopyridine compound of the following formula

Use of pyrazolopyridine compound

The invention relates to a pharmaceutical composition as a therapeutic agent for ischemic disease comprising a compound of the formula ##STR1## wherein R.sup.1 is carbamoyl substituted with morpholino (lower) alkyl, thiomorpholino(lower)alkyl or lower alkylamino(lower)alkyl; or ureido substituted with lower alkylamino(lower)alkyl; and

N-containing heterocyclic compounds, and composition comprising the same

An N-containing heterocyclic compound of the formula: ##STR1## wherein R.sup.1 is lower alkyl optionally substituted with hydroxy, halogen or a heterocyclic group, carboxy, esterified carboxy, carbamoyl optionally substituted with heterocyclic(lower)alkyl or lower alkylamino(lower)alkyl, N-containing heterocycliccarbonyl optionally substituted with lower alkyl, or ureido optionally substituted with lower alkylamino(lower)alkyl, and

Morpholine containing pyridine compounds, compositions and use

Growing community of inventors

Kobe, Japan

Kimio Esumi